Chimerix: Big News, Big Moves, So Maybe Now's The Time To Buy

Group 1 - The article expresses substantial optimism for Chimerix, Inc. (NASDAQ: CMRX) as an investment opportunity based on its price and potential [1] - The author has a PhD in biochemistry and extensive experience analyzing clinical trials and biotech companies, indicating a strong foundation for evaluating the company [1] Group 2 - The article emphasizes the importance of understanding the science behind biotech investments to avoid pitfalls [1]